Can I read Clinical Cardiology - 2023 - Mo - Efficacy of Sacubitril Valsartan and SGLT2 Inhibitors in Heart Failure With Reduced on EtoBox?

Clinical Cardiology - 2023 - Mo - Efficacy of Sacubitril Valsartan and SGLT2 Inhibitors in Heart Failure With Reduced by Luluil Muniroh is a document available to read on EtoBox.

What is Clinical Cardiology - 2023 - Mo - Efficacy of Sacubitril Valsartan and SGLT2 Inhibitors in Heart Failure With Reduced about?

This meta-analysis reviewed studies comparing the efficacy of sacubitril-valsartan (SV) alone or with the addition of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF). It found that combination therapy was associated with reduced risks of all-cause mortality, cardiovascular mortality, and hospitalization for heart failure compared to SV alone.

Author

Luluil Muniroh

Language

EN